The FDA Casts a Closer Eye on Peptide Injections: Decoding the Wellness Trend and Regulatory Scrutiny RFK Jr. Pushes FDA to Open the Door on a Dozen Hot‑Talk Peptides When Getting a GLP-1 is Too Easy: Yale Researchers' Undercover Study Raises Eyebrows The Price Tag Blues: Unpacking Novo Nordisk's Bold Move on Ozempic and Wegovy for Self-Pay Patients